These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 32342352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.
    Pfaar O, van Twuijver E, Boot JD, Opstelten DJ, Klimek L, van Ree R, Diamant Z, Kuna P, Panzner P.
    Allergy; 2016 Jan; 71(1):99-107. PubMed ID: 26417901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
    Kruse K, Gerwin E, Eichel A, Shah-Hosseini K, Mösges R.
    J Allergy Clin Immunol Pract; 2015 Jan; 3(3):381-6. PubMed ID: 25609338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J.
    Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and immunological correlates of pre-co-seasonal sublingual immunotherapy with birch monomeric allergoid in patients with allergic rhinoconjunctivitis.
    Burastero SE, Mistrello G, Paolucci C, Breda D, Roncarolo D, Zanotta S, Falagiani P.
    Int J Immunopathol Pharmacol; 2009 Oct; 22(2):343-52. PubMed ID: 19505388
    [Abstract] [Full Text] [Related]

  • 10. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
    Wahn U, Bachert C, Heinrich J, Richter H, Zielen S.
    Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.
    Bødtger U, Poulsen LK, Jacobi HH, Malling HJ.
    Allergy; 2002 Apr; 57(4):297-305. PubMed ID: 11906359
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL, Bullens D, Kleinjans H, van der Werf J, PURETHAL Birch Efficacy Study Group.
    Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
    [Abstract] [Full Text] [Related]

  • 14. The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Biedermann T, Kuna P, Panzner P, Valovirta E, Andersson M, de Blay F, Thrane D, Jacobsen SH, Stage BS, Winther L.
    J Allergy Clin Immunol; 2019 Mar; 143(3):1058-1066.e6. PubMed ID: 30654054
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension.
    Worm M, Rak S, Samoliński B, Antila J, Höiby AS, Kruse B, Lipiec A, Rudert M, Valovirta E.
    Clin Exp Allergy; 2019 Apr; 49(4):516-525. PubMed ID: 30570787
    [Abstract] [Full Text] [Related]

  • 17. High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real-life clinical study.
    Irani C, Saleh RA, Jammal M, Haddad F.
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):802-7. PubMed ID: 25224283
    [Abstract] [Full Text] [Related]

  • 18. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K, van der Werf JF, Boot D, van Ree R.
    Int Arch Allergy Immunol; 2017 Oct; 172(3):183-186. PubMed ID: 28380494
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, Purohit A, Arvidsson M, Kavina A, Schroeder JW, Mothes N, Spitzauer S, Montagut A, Galvain S, Melac M, André C, Poulsen LK, Malling HJ.
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [Abstract] [Full Text] [Related]

  • 20. Optimum treatment strategies for polyallergic patients - analysis of a large observational trial.
    Shah-Hosseini K, Mioc K, Hadler M, Karagiannis E, Mösges R.
    Curr Med Res Opin; 2015 Dec; 31(12):2249-59. PubMed ID: 26366617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.